Hanzhi Liu - Concepedia

Concepedia

Author

Hanzhi Liu

Chinese Academy of Medical Sciences & Peking Union Medical College ORCID

Also Known As

Han-Zhi Liu, Han-zhi LIU, Hanzhi LIU, Hanzhi Liu, Liu, Hanzhi, Niu, Fengjun

49

Publications

1.3K

Citations

12

H-Index

42

Concepts

All Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College Institute of Hematology & Blood Diseases Hospital Peking University

HL

About

Hanzhi Liu is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	650
2	Cell Biology	6	6	163
3	Cellular Physiology	2	2	26
4	Health Sciences	1	1	32
5	Cellular Therapies	1	1	435

Hanzhi Liu

×

13

Publications

1.3K

Citations

12

H-Index

	Year	Citations
A safe and potent anti-CD19 CAR T cell therapy Zhitao Ying, Xue F. Huang, Xiaoyu Xiang, Nature Medicine Cell TherapyImmunologyAutoimmunityImmunotherapyMedicine	2019	435
Blocking IL-17A Promotes the Resolution of Pulmonary Inflammation and Fibrosis Via TGF-β1–Dependent and –Independent Mechanisms Su Mi, Zhe Li, Hongzhen Yang, The Journal of Immunology	2011	362
Targeting TLR2 Attenuates Pulmonary Inflammation and Fibrosis by Reversion of Suppressive Immune Microenvironment Hongzhen Yang, Bing Cui, Hanzhi Liu, The Journal of Immunology	2009	99
Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine Linping Hu, Kun Ru, Li Zhang, Biomarker Research	2014	99
Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice Ziyan Wang, Jun Yan, Heng Lin, Hepatology	2013	64
NHS-mediated QDs-peptide/protein conjugation and its application for cell labeling☆ Yaming Shan, Liping Wang, Yuhua Shi, Talanta Nhs-mediated Qds-peptide/protein ConjugationPeptide EngineeringProtein EngineeringPeptide TherapeuticsMedicine	2008	53
Efficient inhibition of human B-cell lymphoma xenografts with an anti-CD20×anti-CD3 bispecific diabody Dongsheng Xiong, Yuanfu Xu, Hanzhi Liu, Cancer Letters Lymphoid NeoplasiaAnti-cd20×anti-cd3 Bispecific DiabodyMedicineEfficient InhibitionImmunology	2002	37
Rictor Is Required for Early B Cell Development in Bone Marrow Yingchi Zhang, Tianyuan Hu, Chunlan Hua, PLoS ONE Lymphocyte DevelopmentImmunologyBlood CellMtorc1 InhibitorBone Marrow Failure	2014	32
IL-37b suppresses T cell priming by modulating dendritic cell maturation and cytokine production via dampening ERK/NF-&kappa;B/S6K signalings Wantong Wu, Weiqiang Wang, Yun Wang, Acta Biochimica et Biophysica Sinica Immune RegulationImmunologyImmunologic MechanismCd4 T Cell ResponsesInnate Immunity	2015	27
Rheb1-mTORC1 maintains macrophage differentiation and phagocytosis in mice Xiaomin Wang, Minghao Li, Yanan Gao, Experimental Cell Research Macrophage BiologyInflammationRheb1-mtorc1 MaintainsImmunologyMedicine	2016	25

Page 1